Literature DB >> 27575608

Editorial: Inflammatory Osteoclasts: A Different Breed of Bone Eaters?

Deborah Veis Novack1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27575608      PMCID： PMC5125836          DOI： 10.1002/art.39835

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  10 in total

1.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

2.  TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.

Authors:  A R Pettit; H Ji; D von Stechow; R Müller; S R Goldring; Y Choi; C Benoist; E M Gravallese
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.

Authors:  Lynett Danks; Noriko Komatsu; Matteo M Guerrini; Shinichiro Sawa; Marietta Armaka; George Kollias; Tomoki Nakashima; Hiroshi Takayanagi
Journal:  Ann Rheum Dis       Date:  2015-05-29       Impact factor: 19.103

4.  RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

Authors:  J Li; I Sarosi; X Q Yan; S Morony; C Capparelli; H L Tan; S McCabe; R Elliott; S Scully; G Van; S Kaufman; S C Juan; Y Sun; J Tarpley; L Martin; K Christensen; J McCabe; P Kostenuik; H Hsu; F Fletcher; C R Dunstan; D L Lacey; W J Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 6.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

7.  Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.

Authors:  Stanley B Cohen; Robin K Dore; Nancy E Lane; Peter A Ory; Charles G Peterfy; John T Sharp; Désirée van der Heijde; Lifen Zhou; Wayne Tsuji; Richard Newmark
Journal:  Arthritis Rheum       Date:  2008-05

8.  RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Authors:  Ping Li; Edward M Schwarz; Regis J O'Keefe; Lin Ma; Brendan F Boyce; Lianping Xing
Journal:  J Bone Miner Res       Date:  2004-02       Impact factor: 6.741

9.  RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.

Authors:  Susan Li; Christine H Miller; Eugenia Giannopoulou; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 19.456

10.  Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.

Authors:  H G Bone; D W Dempster; J A Eisman; S L Greenspan; M R McClung; T Nakamura; S Papapoulos; W J Shih; A Rybak-Feiglin; A C Santora; N Verbruggen; A T Leung; A Lombardi
Journal:  Osteoporos Int       Date:  2014-11-29       Impact factor: 4.507
  10 in total
  6 in total

1.  A library of Rhodamine6G-based pH-sensitive fluorescent probes with versatile in vivo and in vitro applications.

Authors:  W Benton Swanson; Margaret Durdan; Miranda Eberle; Seth Woodbury; Ava Mauser; Jason Gregory; Boya Zhang; David Niemann; Jacob Herremans; Peter X Ma; Joerg Lahann; Megan Weivoda; Yuji Mishina; Colin F Greineder
Journal:  RSC Chem Biol       Date:  2022-04-29

2.  Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model.

Authors:  Mario M Zaiss; Christopher Hall; Neil W A McGowan; Rebecca Babb; Vikesh Devlia; Sébastien Lucas; Sajeda Meghji; Brian Henderson; Aline Bozec; Georg Schett; Jean-Pierre David; Gabriel S Panayi; Agamemnon E Grigoriadis; Valerie M Corrigall
Journal:  ACR Open Rheumatol       Date:  2019-08-03

3.  Conditional Controlled Light/Dark Cycle Influences Exercise-Induced Benefits in a Rat Model with Osteoarthritis: In Vitro and In Vivo Study.

Authors:  Yunkyung Hong; Seunghoon Lee; Jeonghyun Choi; Yunho Jin; Jinyoung Won; Yonggeun Hong
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

4.  Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis.

Authors:  Sushmita Chakraborty; Bianca Kloos; Ulrike Harre; Georg Schett; Katharina F Kubatzky
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 5.  Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.

Authors:  Yongsheng Ruan; Hye Na Kim; Heather Ogana; Yong-Mi Kim
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

6.  Physiologic osteoclasts are not sufficient to induce skeletal pain in mice.

Authors:  Larissa de Clauser; Sonia Santana-Varela; John N Wood; Shafaq Sikandar
Journal:  Eur J Pain       Date:  2020-10-12       Impact factor: 3.931
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.